PAREXEL International Corp (NASDAQ:PRXL)
| CAPS Rating |
|
|---|---|
| Open | $24.05 |
| Previous Close | $24.29 |
| Daily Range | $23.75 - $24.26 |
| 52-Week Range | $15.26 - $27.91 |
| Market Cap | $1.42B |
| P/E Ratio | 25.70 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 193,823 |
| Average Daily Volume | 0 |
PRXL
VS S&P 500 (SPY)
How do you think PRXL will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PRXL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PRXL News and Commentary
- PAREXEL International Shares Popped: What You Need to Know – The Motley Fool
- Golf Clap for PAREXEL International – The Motley Fool
- Should You Get Out of ICON Before Next Quarter? – The Motley Fool
- Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom – The Motley Fool
- Pharmaceutical Product Development Shares Soared: What You Need to Know – The Motley Fool
- Is PAREXEL International Going to Burn You? – The Motley Fool
- Is ICON the Perfect Stock? – The Motley Fool
- Rising Star Buy: More Icon – The Motley Fool
- Parexel Shares Popped: What You Need to Know – The Motley Fool
- PAREXEL International Earnings Preview – The Motley Fool
- Rising Stars Buy: Icon – The Motley Fool
- Are Shorts Watching This Number at Covance? – The Motley Fool
- Does This Mean ICON Will Bomb Next Quarter? – The Motley Fool
- Parexel Shares Plunged: What You Need to Know – The Motley Fool
- Wall Street Breakfast: Must-Know News – SeekingAlpha
- Omnicare Passes This Key Test – The Motley Fool
- Is PPD's Stock a Bargain by the Numbers? – The Motley Fool
- Parexel Shares Plunged: What You Need to Know – The Motley Fool
- Why Pharmaceutical Product Development's Earnings Are Outstanding – The Motley Fool
- Here's How Pharmaceutical Product Development May Be Failing You – The Motley Fool
RSS Headlines
Fool UK
